Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Hyperthyroidism

Population Covered By The Guidance

This pathway provides guidance on the investigation of adult patients with hyperthyroidism.

Lead Researcher: Sian Chin, Arjun Shivananda

Experts & Contributors: Ravinder Dhillon, David Hurley, Anita Kothapalli, Kyaw Thura

Editorial Panel: Core membership
Link to Editorial Panel

Date reviewed: February 2018

Date Published: June 2018

Image 1a and 1b (Thyroid Scintigraphy - Tc99m Pertechnetate): The thyroid gland has taken up 6.3% of the administered dose (normal between 0.6-2.7%). This is evenly distributed throughout both lobes of the thyroid gland. No focal abnormalities are demonstrated. The appearances are typical of Graves' Disease.

Graves' Disease

Image 1a and 1b (Thyroid Scintigraphy - Tc99m Pertechnetate): The thyroid gland has taken up 6.3% of the administered dose (normal between 0.6-2.7%). This is evenly distributed throughout both lobes of the thyroid gland. No focal abnormalities are demonstrated. The appearances are typical of Graves' Disease.

Graves' Disease

Image 2 (H&E, x10): Histological section of Graves' disease showing hyperplastic follicles with infolding of the follicular epithelium to form papillary projections (blue arrow). The colloid is pale with scalloped margins (green arrows).

Graves' Disease

Image 3a, 3b, 3c and 3d (Computed Tomography): The right lobe of the thyroid is considerably enlarged with retrosternal extension and deviation of the trachea to the left (arrows). There are a few mediastinal nodes which measure around 1cm in short axis diameter.

Retrosternal Goitre

Image 3a, 3b, 3c and 3d (Computed Tomography): The right lobe of the thyroid is considerably enlarged with retrosternal extension and deviation of the trachea to the left (arrows). There are a few mediastinal nodes which measure around 1cm in short axis diameter.

Retrosternal Goitre

Image 3a, 3b, 3c and 3d (Computed Tomography): The right lobe of the thyroid is considerably enlarged with retrosternal extension and deviation of the trachea to the left (arrows). There are a few mediastinal nodes which measure around 1cm in short axis diameter.

Retrosternal Goitre

Image 3a, 3b, 3c and 3d (Computed Tomography): The right lobe of the thyroid is considerably enlarged with retrosternal extension and deviation of the trachea to the left (arrows). There are a few mediastinal nodes which measure around 1cm in short axis diameter.

Retrosternal Goitre

Image 4a: Total thyroidectomy showing a multinodular goitre with marked asymmetrical enlargement of the right lobe due to a massive dominant nodule

Multinodular (Colloid) Goitre

Image 4b (H&E, x2.5): Histological section of a multinodular (colloid) goitre showing the usual features of variously sized, colloid-containing follicles lined by uniform epithelial cells, patchy areas of haemorrhage and fibrosis.

Multinodular (Colloid) Goitre

  • Graves' disease can often be diagnosed clinically and appropriate medication commenced
  • If the aetiology of hyperthyroidism is uncertain, isotope scan may aid in the diagnosis based on the pattern and location of radionuclide uptake

Date of literature search: September 2017

References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document

  1. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906-18. (Review article). View the reference
  2. Lacka K, Fraczek MM. Classification and etiology of hyperthyroidism. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2014;36(213):206-11. (review article). View the reference
  3. Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging. 2002;29 Suppl 2:S425-38. (Review article). View the reference
  4. Summaria V, Salvatori M, Rufini V, Mirk P, Garganese MC, Romani M. Diagnostic imaging in thyrotoxicosis. Rays. 1999;24(2):273-300. (Review article). View the reference
  5. Alimanovic-Alagic R, Brkovic A, Kucukalic-Selimovic E, Skopljak-Beganovic A. Thyroid scintigraphy as diagnostic method evaluation of thyroid diseases. Med Arh. 2008;62(2):114-6. (Review article). View the reference
  6. Smith JR, Oates E. Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls. Clin Nucl Med. 2004;29(3):181-93. (Review article). View the reference
  7. Intenzo CM, dePapp AE, Jabbour S, Miller JL, Kim SM, Capuzzi DM. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003;23(4):857-69. (Review article). View the reference
  8. Kusic Z, Becker DV, Saenger EL, Paras P, Gartside P, Wessler T, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J Nucl Med. 1990;31(4):393-9. (Level III evidence). View the reference
  9. Gupta V. Physiopathologic atlas of thyroid scintigraphy. Kathmandu University medical journal (KUMJ). 2007;5(4):583-90. (Review article). View the reference
  10. Meng Z, Zhang G, Sun H, Tan J, Yu C, Tian W, et al. Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters. Experimental and Therapeutic Medicine. 2015;9(6):2165-72. (Level III evidence). View the reference

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

Date reviewed: March 2018Please note that this pathway is subject to review and revisionSUSPECTED HYPERTHYROIDISMFocal activity / suppressed uptake elsewhereDiffuse uptakeTypical clinical presentation for Graves' Disease, including elevated TSH-R antibody?Consider a TSH-secreting adenoma or thyroid hormone resistanceThyroid scintigraphy (isotope scan)Low TSH, high T3 and T4Non suppressed TSH, high T3 and/or T4Decreased activityMay proceed to treatment - imaging often not requiredLikely Graves' diseaseNoYesHeterogeneous activityLikely Thyroiditis - subacute (granulomatous) - silent (lymphocytic) - postpartumLikely toxic multinodular goitreLikely hyperfunctioning adenoma

Hyperthyroidism

Hyperthyroidism

Defined as elevated serum free T4 and/or T3 with typical symptoms and signs

  • Hyperthyroidism is diagnosed when there is elevation of serum free T4 and/or T3 accompanied by typical symptoms and signs. Biochemical evidence without clinical manifestations is referred to as subclinical hyperthyroidism. Antibody interference in thyroid assays should be considered when interpreting results
  • Common causes of hyperthyroidism include Graves' disease and toxic multinodular goitre; also consider functioning thyroid adenoma and thyroiditis
  • The role of imaging in hyperthyroidism is to help establish the cause and this is usually done with a thyroid isotope scan
  • Elevated T3 and T4 are usually accompanied by low levels of TSH. However, rarely hyperthyroidism is driven by high TSH levels in which case a TSH-secreting pituitary adenoma or thyroid hormone resistance should be excluded
  • Typical cases of Graves' disease such as those with a diffuse goitre, ophthalmopathy and serological evidence may treated without any prior imaging although scintigraphy may help confirm the diagnosis and exclude other causes

Thyroid Hormone Resistance

Thyroid Hormone Resistance

A rare genetic syndrome where thyroid hormone levels are elevated but TSH is not suppressed, caused by an inactivation mutation of the thyroid receptor gene

Typical Signs of Graves’ Disease Include

Typical Signs of Graves’ Disease Include

  • Hyperthyroidism
  • Ophthalmopathy
  • Diffuse goitre
  • Thyrotropin (TSH) receptor antibodies

Thyroid Isotope Scan (Thyroid Scintigraphy)

Thyroid Isotope Scan

Usually performed with technetium-99m pertechnetate

  • Usually performed with technetium-99m pertechnetate or radioiodine
  • Advantages of technetium-99m pertechnetate
    • Lower radiation dose
    • Better image quality
    • Less waiting time after administration
    • Wider availability
    • Lower cost
    • Images can be obtained while the patient is taking anti-thyroid medications
  • Advantages of radioiodine
    • Has lower levels of vascular background activity which is useful when assessing retrosternal masses
    • Has some advantages in the evaluation of thyroid nodules, although these are rarely of clinical significance
    • Oral administration
  • Scintigraphy is particularly useful for distinguishing Graves' disease from conditions such as subacute, silent and postpartum thyroiditis and factitious hyperthyroidism
  • It is also useful for demonstrating toxic adenomas

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Endocrine

    • Endocrine
      • Adrenal Lesion (Incidental)
      • Adrenal Mass (Incidental on CT)
      • Cushing's syndrome
      • Goitre (investigation)
      • Hyperaldosteronism (primary suspected)
      • Hyperparathyroidism (primary suspected)
      • Hyperthyroidism
      • Osteoporosis (suspected)
      • Phaeochromocytoma (suspected)
      • Thyroid nodule (incidental)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content